Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters.
To define the role of neutrophil elastase (NE) in the progression of acute lung injury (ALI), we examined the effects of post-treatment with a specific NE inhibitor, sivelestat sodium hydrate (sivelestat), on ALI induced by endotoxin (ET) inhalation in hamsters. Inhalation of ET (300 microg/ml, 30 min) in conscious hamsters increased inflammatory cell count, protein concentration, and hemorrhage in bronchoalveolar lavage fluid (BALF) that peaked 24 h after ET inhalation. These changes were significant 2 h after ET inhalation and paralleled the increase in NE activity in BALF. When intravenously infused from 2 to 24 h post-ET inhalation, sivelestat (0.03 to 3 mg/kg/h) dose-dependently attenuated changes in these BALF parameters at 24 h post-ET inhalation in a manner dependent on the inhibition of NE activity in BALF. Histopathological analysis also indicated that sivelestat prevented the progression of lung inflammation such as alveolar neutrophil infiltration and hemorrhage. In contrast, dexamethasone (3 mg/kg, intravenously) was not effective in this model when administered 2 h after ET inhalation, although it was highly effective when applied before ET. We conclude that delayed inhibition of NE activity with sivelestat prevents subsequent progression of ALI in hamsters after ET inhalation. Thus NE may play an important role in the progression of ALI.
Kawabata
K
K
Minase Research Institute, Ono Pharmaceutical Co., Ltd., Osaka, Japan.
Hagio
T
T
Matsumoto
S
S
Nakao
S
S
Orita
S
S
Aze
Y
Y
Ohno
H
H
D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000276:immunology; D006224:Cricetinae; D018450:Disease Progression; D004731:Endotoxins; D005998:Glycine / Q000031:analogs & derivatives* / Q000494:pharmacology; D007958:Leukocyte Count; D019272:Leukocyte Elastase / Q000037:antagonists & inhibitors* / Q000502:physiology; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008297:Male; D008647:Mesocricetus; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology; D012128:Respiratory Distress Syndrome / Q000276:immunology* / Q000473:pathology; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology*
D004731:Endotoxins; D015842:Serine Proteinase Inhibitors; D013449:Sulfonamides; C069195:sivelestat; D019272:Leukocyte Elastase; D005998:Glycine